Kamila Kaźmierczak

Ms. Kamila Kaźmierczak


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2021 in Ginekologia Polska
Verified
Journal Article
Closed access
PDF file
KKKamila Kaźmierczak
Kamila Kaźmierczak
BNBłazej Nowakowski
Błazej Nowakowski
The role and place of a radical hysterectomy in the concept of cervical cancer treatment, despite over one hundred years of its traditional use, still excites controversy. To fully understand the value of the surgical treatment, it is worth analysing and understanding the evolutionary path of the radical hysterectomy and the changes that have occurred in this method over the years. This knowledge will allow for a better understanding as to why the choice of therapy between surgery and radiochemotherapy in the early and locally advanced stages of cervical cancer still raise doubts. Both the introduced changes in the scope of surgery and the use of multi-module treatment - surgery with subsequent radiation therapy did not significantly improve the results of cancer treatment, but significantly increased the prevalence of side effects and therapy complications. As cervical cancer most often affects relatively young women, the number of potential years of life after treatment is high. Over 30% of women in Poland with cervical cancer are in the 45–49 years-old age group. From the perspective of these data, obtaining a high therapeutic index, which is defined as the ratio of the number of healed patients to complications and side effects of treatment significantly reducing the quality of life, is very important in the therapy process. Regardless of the classical radical surgery, which has evolved over many years, a new concept of radical hysterectomy based on tissue morphogenesis, called total mesometrial resection (TMMR) with therapeutic Lymph Node Dissection (tLND) with no adjuvant radiotherapy, has recently been proposed. Based on the ontogenetic research and the study of cancerous tumour development, the concept of TMMR was first introduced by M. Höckel in 2001. In the research conducted by the author, encouraging results of the treatment of stages IB1, IB2, IIA1 and IIA2, and selected cases of stage IIB [according to 2009 International Federation of Gynecology and Obstetrics (FIGO)] cervical cancer were obtained. The role and place of a radical hysterectomy in the concept of cervical cancer treatment, despite over one hundred years of its traditional use, still excites controversy. To fully understand the value of the surgical treatment, it is worth analysing and understanding the evolutionary path of the radical hysterectomy and the changes that have occurred in this method over the years. This knowledge will allow for a better understanding as to why the choice of therapy between surgery and radiochemotherapy in the early and locally advanced stages of cervical cancer still raise doubts. Both the introduced changes in the scope of surgery and the use of multi-module treatment - surgery with subsequent radiation therapy did not significantly improve the results of cancer treatment, but significantly increased the prevalence of side effects and therapy complications. As cervical cancer most often affects relatively young women, the number of potential years of life after treatment is high. Over 30% of women in Poland with cervical cancer are in the 45–49 years-old age group. From the perspective of these data, obtaining a high therapeutic index, which is defined as the ratio of the number of healed patients to complications and side effects of treatment significantly reducing the quality of life, is very important in the therapy process. Regardless of the classical radical surgery, which has evolved over many years, a new concept of radical hysterectomy based on tissue morphogenesis, called total mesometrial resection (TMMR) with therapeutic Lymph Node Dissection (tLND) with no adjuvant radiotherapy, has recently been proposed. Based on the ontogenetic research and the study of cancerous tumour development, the concept of TMMR was first introduced by M. Höckel in 2001. In the research conducted by the author, encouraging results of the treatment of stages IB1, IB2, IIA1 and IIA2, and selected cases of stage IIB [according to 2009 International Federation of Gynecology and Obstetrics (FIGO)] cervical cancer were obtained.

24 March 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
Paweł UruskiPaweł Uruski
Paweł Uruski
JMJustyna Mikula-Pietrasik
Justyna Mikula-Pietrasik
ENEryk Naumowicz
Eryk Naumowicz
KKKamila Kaźmierczak
Kamila Kaźmierczak
AGAndrey Gaiday
Andrey Gaiday
KKKrzysztof Książek
Krzysztof Książek
The mechanisms and clinical significance of the cellular senescence of tumor cells are a matter of ongoing debate. Recently, the triggers and molecular events underlying spontaneous, replicative senescence of primary epithelial ovarian cancer cells were characterized. In this study, we reanalyzed tumors obtained from ovarian cancer patients with respect to the expression of the senescence biomarkers SA-β-Gal and γ-H2A.X and the proliferative antigen Ki67. The results showed that the tumors displayed strong heterogeneity with respect to the expression of analyzed markers. The expression of SA-β-Gal and γ-H2A.X in the oldest patients (61–85 y.o.) was significantly higher than in the younger age groups. Conversely, the area of Ki67-positive cancer cells was greater in younger individuals. At the same time, there was a positive correlation between SA-β-Gal expression and calendar age in FIGO III–IV and malignant ascites-positive patients. The γ-H2A.X positively correlated with age in the whole group, FIGO III–IV, and ascites-positive patients. Ki67 levels correlated negatively with the age of patients among those same groups. Collectively, our study indicated that organismal aging may determine the development of the senescence phenotype in ovarian tumors, particularly in patients with advanced disease and those accumulating malignant ascites.

1 January 2021 in Contemporary Oncology
Verified
Journal Article
Open access
KKKamila Kaźmierczak
Kamila Kaźmierczak
WCWitold Cholewiński
Witold Cholewiński
BNBłażej Nowakowski
Błażej Nowakowski
Introduction According to the literature, fluor-18-fluorodeoxyglucose positron emission tomography with computed tomography ( 18 F-FDG-PET-CT) is the most effective technique for the examination and detection of metastases in the lymph nodes in patients with cervical cancer. This study aimed to...

17 May 2019 in Oncology in Clinical Practice
Verified
Journal Article
Closed access
KKKamila Kaźmierczak
Kamila Kaźmierczak
JKJoanna Kufel-Grabowska
Joanna Kufel-Grabowska
TKTomasz Kozłowski
Tomasz Kozłowski
BNBłażej Nowakowski
Błażej Nowakowski

1 January 2021 in Contemporary Oncology
Verified
Journal Article
Open access
PDF file
KKKamila Kaźmierczak
Kamila Kaźmierczak
WCWitold Cholewiński
Witold Cholewiński
BNBłażej Nowakowski
Błażej Nowakowski
An ectopic pregnancy occurs in approximately 0.5–2% of all pregnancies. The number of cases of cervical cancer in women under 30 years of age in Poland is less than 100 cases per year. The case presented herein concerns a rare clinical situation of a 29-year-old woman admitted to the...